Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia

NCT05706454 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

324

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19 Pneumonia
COVID-19 Respiratory Infection

Interventions

DRUG: Ramatroban
DRUG: Placebo

Sponsor

KARE Biosciences

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]